CT-image based conformal high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer - Introducing the procedure

Reports of Practical Oncology and Radiotherapy

Volumn 13, Issue 5, 2008, Pages 227-239

  Kubaszewska, Magda ^a   Dymnicka, Magdalena ^a   Skowronek, Janusz ^a   Chicheł, Adam ^a   Kanikowski, Marek ^a  

^a Great Poland Cancer Centre   (Poland)

Author keywords

Boost; Breast conserving therapy; CT based treatment planning; HDR brachytherapy; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BRACHYTHERAPY; BREAST CANCER; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; RADIATION DOSE; RECURRENCE RISK; SEGMENTAL MASTECTOMY; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

EID: 63649098652     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1507-1367(10)60092-2     Document Type: Article

References (44)

1. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 2002; 347: 1233-41
2. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized trial comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med, 2002;347:1227-32
3. Bartelink H, Horiot JC, Poortmans P, et al: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med, 2001; 345: 1378-87
4. Gerbaulet A, Potter R, Mazeron JJ, et al: The GEC ESTRO Handbook of Brachytherapy, Bruksela 2002
5. Wazer DE, Berle L, Graham R, et al: Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys, 2002; 53: 889-97
6. Polgar C, Sulyok Z, Fodor J, et al: Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol, 2002; 80: 121-8
7. Borger JH, Kemperman H, Smitt HS, et al: Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys, 1994; 30: 1073-81
8. Romestaing P, Lehingue Y, Carrie C, et al: Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol, 1997; 15: 963-8
9. Skowronek J: Brachyterapia PDR (pulsacyjna) w leczeniu. raka piersi, Wsp Onkol 2007; 2: 72-81
10. De la Rochefordière A, Abner AL, Silver B, et al: Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique? Int J Radiat Oncol Biol Phys, 1992; 23: 925-31
11. Habibollahi F, Mayles HM, Mayles WP, et al.: Assessment of skin dose and its relation to cosmesis in the conservative treatment of early breast cancer. Int J Radiat Oncol Biol Phys, 1988; 14: 291-6
12. Harris JR, Levene MB, Svenson G, et al: Analysis of cosmetic results following primary radiation for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys, 1979; 5: 257
13. Recht A, Silver B, Schnitt SJ, et al: Breast relapse following primary radiation therapy for early breast cancer I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys, 1985; 11: 1271-6
14. Van Limbergen E, Van den Bogaert W, Van der Schueren E, et al: Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. Radiother Oncol, 1987; 8: 1-9.
15. Hammer J, Seewald D, et al: Use of HDR after-loading method in the treatment of breast cancer. Strahlenther Onkol, 1988; 82:Suppl: 271-3.
16. Hammer J, Mazeron JJ, van Limbergen E: Breast boost - Why, how, when? Strahlenther Onkol, 1999; 175: 478-83
17. Kurtz JM: Which patients don't need a tumor-bed boost after whole-breast radiotherapy? Strahlenther Onkol, 2001; 177: 33-36
18. Polga'r C, Fodor J, Orosz Z, et al: Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer: First results of the randomized Budapest boost trial. Strahlenther Onkol, 2002; 178: 615-23
19. Hammer J, Seewald DH, Track C, et al: Breast cancer: primary treatment with external-beam radiation therapy and high-dose-rate iridium implantation. Radiology, 1994; 193: 573-7
20. Fowble B, Solin LJ, Martz KL, et al: The influence of the type of boost (electrons vs implant) on local control and cosmesis in patients with stages I and II breast cancer undergoing conservative surgery and radiation. Int J Radiat Oncol Biol Phys, 1986; 12: 150
21. Hammer J, Track C, Seewald DH, et al: 192-iridium HDR boost in breast cancer treatment - experience from 644 patients. Radiother Oncol, 2000; 55: Suppl 1:32
22. Frazier RC, Kestin LL, Kini V, et al: Impact of boost technique on outcome in early-stage breast cancer patients treated with breast conserving therapy. Am J Clin Oncol, 2001; 24: 26-32
23. Kovacs G, Hebbinghaus D, Dennert P, et al: Conformal treatment planning for interstitial brachytherapy. Stahlenther Onkol, 1996; 172: 469-74
24. Polgar C, Major T, Somogyi A, et al: CT-image based conformal brachytherapy of breast cancer: the significance of semi-3D and 3-D treatment planning. Strhlenther Onkol, 2000; 176: 118-24
25. Hammer J, Track C, Seewald DH, et al: 192-iridium HDR boost in breast cancer treatment - experience from 644 patients. Radiother Oncol, 2000; 55 (Suppl. 1): 32
26. ICRU Report 58. Dose and volume specification for reporting interstitial therapy. Bethesda, Maryland: ICRU, 1997: 1-35
27. Clarke DH, Le MG, Sarrazin D et al: Analysis of localregional relapses in patient with early breast cancer treated by excision and radiotherapy. Experience of the Institute Gustave Roussy. Int J Radiat Oncol Biol Phys, 1985; 11: 137-45
28. Collette L, Fourquent A, Horiot JC, et al: Impact of boost dose of 16 Gy on local control in patients with early breast cancer: the EORTC "Boost vs no boost" trial. (Abstract) Radiother Oncol, 2001;56 (Suppl. 1); 46
29. Nagykálnai T, Nemeskéri Cs, Mayer Á, et al: Effectivity of boost radiotherapy on the local recurrence rate following breast conserving surgery plus whole breast irradiation. Proceedings of the 2nd European Congress on Senology, 1994; 591-6
30. Teissier E, Héry M, Ramaioli A, et al: Boost in conservative treatment: 6 year results of randomized trial. Breast Cancer Res Treat, 1998; 50: 345
31. Berberich W, Schnabel K, Berg D, et al: Boost irradiation of breast carcinoma: teletherapy vs brachytherapy. Eur Obstet Gynecol Reprod Biol, 2001;94:276-82
32. Frazier RC, Kestin LL, Kini V, et al: Impact of boost technique on outcome in early stage breast cancer patients treated with breast conserving therapy. Am J Clin Oncol, 2001; 24: 26-37
33. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al: Factors determining outcome for breast conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys, 1998; 40: 851-8
34. Van Limbergen E: What are the optimal boost methods in relation to boost target depth in the breast? Proceedings of the Consensus Meeting on Breast Cancer: To boost or not to boost and how to do it. GEC-ESTRO, 2001; 105-14
35. Hennequin C, Durdux C, Espié M, et al: High-dose-rate brachytherapy for early breast cancer: an ambulatory technique. Int J Radiat Oncol Biol Phys, 1999; 45: 85-90
36. DeBiose DA, Horwitz EM, Martinez AA, et al: The use of ultrasonography in the localization of the lumpectomy cavity for interstitial brachytherapy of the breast. Int J Radiat Oncol Biol Phys, 1997; 38: 755-9
37. Rabinovitch R, Finlayson C, Pan Z, et al: Radiographic evaluation of surgical clips is better than ultrasound for defining the lumpectomy cavity in breast boost treatment planning: a prospective clinical study. Int J Radiat Oncol Biol Phys, 2000; 47: 313-7
38. Gatzemeier W, Orecchia R, Gatti G, et al: Intraoperative radiation therapy (IORT) in the treatment of breast cancer - a new therapeutic alternative in the conservative treatment of breast cancer? Its potential role and future perspectives. Experiences from the European Institute of Oncology (EIO), Milan. Strahlenther Onkol, 2001; 177: 330-7
39. Polgar C, Major T, Somogyi A, et al: CT-image based conformal brachytherapy of breast cancer: The significance of semi-3-D and 3-D treatment planning. Strahlenther Onkol, 2000; 176: 118-24
40. Polgar C: Radiotherapy of the tumor bed after breast conserving surgery for stage I-II breast cancer: Analysis of efficacy of conventional and novel radiotherapy methods. PhD Theses, Budapest, 2001. (in Hungarian)
41. Vicini FA, Jaffray DA, Horwitz EM, et al: Implementation of 3D-virtual brachytherapy in the management of breast cancer: a description of a new method of interstitial brachytherapy. Int J Radiat Oncol Biol Phys, 1998; 40: 629-35
42. Vicini FA, Horwitz EM, Lacerna MD, et al: Long term outcome with interstitial brachytherapy in the management of patient with early breast cancer treated with breast conserving therapy. Int J Radiat Oncol Biol Phys,1997; 37: 845-52
43. Biber E, Resch A, Langbauer G, et al HDR-brachytherapy boost for T1/ T2-breast cancer - first results of a long term follow up. Radiother Oncol, 1998;47:Suppl 1:S2.
44. Hammer J, Track C, Seewald DH, et al: Breast cancer: External beam radiotherapy and interstitial iridium implantation - 10-year clinical results. EJC, 1998;34:Suppl 1:32.abstract